Výsledky vyhledávání - "Vit Martin Matejka"

Post-treatment recovery of suboptimal DNA repair capacity and gene expression levels in colorectal cancer patients

Autor: Vlasta Korenkova, Barbara Pardini, Ludovit Bielik, Francesca Cordero, Miroslav Levy, Vaclav Liska, Tomas Buchler, Pavel Vodicka, Vit Martin Matejka, Pavel Pitule, Mikael Kubista, Veronika Vymetalkova, Ludmila Vodickova, Alessio Naccarati, Jana Slyskova

Publikováno v: Molecular Carcinogenesis. 54:769-778

DNA repair in blood cells was observed to be suboptimal in cancer patients at diagnosis, including colorectal cancer (CRC). To explore the causality of this phenomenon, we studied the dynamics of DNA repair from diagnosis to 1 yr followup, and with r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::24871607a12c89295a13ba5ffb256a28
https://doi.org/10.1002/mc.22141

Zobrazit plný text záznamu

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab

Autor: Marie Bartoušková, Vaclav Liska, Monika Sedivcova, Zbynek Bortlicek, Jindrich Finek, Vit Martin Matejka, Bohuslav Melichar, Lubos Holubec, Jana Kulhankova, Tomas Buchler, Ondrej Topolcan, Beatrice Mohelnikova-Duchonova, Ondrej Fiala

Publikováno v: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 37(5)

The v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are found in 35–45 % of colorectal cancer (CRC) cases. Although the association between the RAS signaling and angiogenesis is well known, the negative predictive value of KRA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bf9867dd99fba7ad82acc6fc7afc441
https://pubmed.ncbi.nlm.nih.gov/26662311

Zobrazit plný text záznamu

The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study

Autor: Jindrich Finek, Vaclav Liska, Jana Kulhankova, Tomas Buchler, Zbynek Bortlicek, Lubos Holubec, Ondrej Fiala, Ondrej Topolcan, Vit Martin Matejka

Publikováno v: Targeted oncology. 10(4)

The aim of our retrospective study was to analyze the association of selected tumor markers (TMs) including serum carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), thymidine kinase, and tissue polypeptide specific antigen with outc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aceb24f45b9b9225e04a8e8441461789
https://pubmed.ncbi.nlm.nih.gov/25875421

Zobrazit plný text záznamu

THE DIFFERENCE IN THE SERUM LEVELS OF BDNF, IL-6, IL-8, IL-10 AND EGF IN ONCOLOGY PATIENTS DIVIDED ACCORDING TO THE PRESENCE OF SYMPTOMS OF DEPRESSION

Autor: Tomáš Svoboda, Jana Dreslerova, Ondřej Fiala, Jindra Vrzalova, Lubos Holubec, Jindřich Fínek, Ondrej Topolcan, J. Podlipny, Vit Martin Matejka

Publikováno v: ResearcherID

Objective To assess the differences in the serum levels of Brain-derived neurotrophic factor (BDNF), interleukin 6 (IL-6), interleukin 8 (IL-8), interleukin 10 (IL-10) and epidermal growth factor (EGF) in oncology patients with symptoms of depression

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f912d75ad4b5d3bd25dcf26f2a839b51
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000309409002393&KeyUID=WOS:000309409002393

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání